LIN - Linde plc
XETRA
->
Basic Materials
->
Specialty Chemicals
Guildford,
United Kingdom
Type: Equity
LIN price evolution
LIN
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $5126 | $5227 | $5226 | $4914 |
| Inventory | $2087 | $2094 | $2100 | $2115 |
| Total current assets | $13460 | $12843 | $13102 | $12620 |
| Long term investments | ||||
| Property, plant & equipment | $25124 | $24575 | $24418 | $24552 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $82546 | $80215 | $80347 | $80811 |
| Current liabilities | ||||
| Accounts payable | $2845 | $2859 | $2885 | $3020 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $14049 | $13504 | $14389 | $15717 |
| Long term debt | $17475 | $16931 | $15227 | $13397 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $43373 | $42036 | $41518 | $41091 |
| Shareholders' equity | ||||
| Retained earnings | $11585 | $10721 | $9708 | $8845 |
| Other shareholder equity | -$6059 | -$6794 | -$6528 | -$5805 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2025 | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2823 | |||
| Short term investments | ||||
| Net receivables | $4914 | $4683 | $4633 | |
| Inventory | $2115 | $1978 | $1733 | |
| Total current assets | $12620 | $13047 | $10159 | |
| Long term investments | $2637 | |||
| Property, plant & equipment | $24552 | $23548 | $27019 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $80811 | $79658 | $81605 | |
| Current liabilities | ||||
| Accounts payable | $3020 | $2995 | $3503 | |
| Deferred revenue | ||||
| Short long term debt | $1709 | |||
| Total current liabilities | $15717 | $16479 | $13643 | |
| Long term debt | $13397 | $12198 | $11335 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $41091 | $39630 | $37570 | |
| Shareholders' equity | ||||
| Retained earnings | $8845 | $20541 | $18710 | |
| Other shareholder equity | -$5805 | -$5782 | -$5048 | |
| Total shareholder equity | $44035 | |||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $8356 | $8302 | ||
| Cost of revenue | ||||
| Gross Profit | $4000 | $3871 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $1769 | $1845 | ||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $498 | $459 | ||
| Interest expense | -$68 | -$71 | ||
| Net income | ||||
| Net income | $1550 | $1543 | ||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $33364 | $30793 | $27243 | |
| Cost of revenue | $17543 | $15383 | ||
| Gross Profit | $13914 | $13250 | $11860 | |
| Operating activities | ||||
| Research & development | $143 | $152 | ||
| Selling, general & administrative | $2997 | $3016 | ||
| Total operating expenses | $7494 | $25292 | $23137 | |
| Operating income | $5501 | $4106 | ||
| Income from continuing operations | ||||
| EBIT | $5501 | $4106 | ||
| Income tax expense | $1434 | $1262 | $847 | |
| Interest expense | -$98 | -$170 | -$239 | |
| Net income | ||||
| Net income | $4147 | $3826 | $2501 | |
| Income (for common shares) | $3826 | $2501 | ||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$3268 | -$2311 | -$1041 | -$4670 |
| Financing activities | ||||
| Dividends paid | -$1996 | -$1334 | -$669 | -$2482 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$2749 | -$1476 | -$668 | -$5400 |
| Effect of exchange rate | -$74 | -$134 | -$61 | -$7 |
| Change in cash and equivalents | $523 | -$38 | $184 | -$772 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | $3826 | $2501 | ||
| Operating activities | ||||
| Depreciation | $4635 | $4626 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $9725 | $7429 | ||
| Investing activities | ||||
| Capital expenditures | -$3086 | -$3400 | ||
| Investments | ||||
| Total cash flows from investing | -$4670 | -$3088 | -$3007 | -$2986 |
| Financing activities | ||||
| Dividends paid | -$2482 | -$2344 | -$2189 | -$2028 |
| Sale and purchase of stock | ||||
| Net borrowings | -$514 | $1313 | ||
| Total cash flows from financing | -$5400 | -$3089 | -$7588 | -$3345 |
| Effect of exchange rate | -$7 | -$74 | -$61 | -$44 |
| Change in cash and equivalents | -$772 | $2613 | -$931 | $1054 |
News
Fundamentals
| Market cap | $191.89B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 476.16M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.96 |
| Quick ratio | 0.81 |